This compound is a pharmaceutical intermediate featuring a pyrrolidine ring with bromoacetyl and benzyl ester substituents. It is primarily used in the manufacturing of active pharmaceutical ingredients.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1428243-26-8
(3R,4S)-1-((benzyloxy)carbonyl)-4-ethylpyrrolidine-3-carboxylic acid Dicyclohexylamine Salt
Pharmaceutical intermediate
(3R,4S)-1-((Benzyloxy)carbonyl)-4-ethylpyrrolidine-3-carboxylic acid
Pharmaceutical intermediate
8-((3R,4S)-4-ethylpyrrolidin-3-yl)-3-tosyl-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine
Pharmaceutical intermediate
4-Desmethoxy-4-nitro Omeprazole Sulfide
Pharmaceutical intermediate for omeprazole analogs
N1-methylpseudouridine-5'-triphosphate
pharmaceutical intermediate
Fezolinetant Impurity 3
Pharmaceutical intermediate
Benzyl (3S,4S)-3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate
Pharmaceutical intermediate for synthesis
Sulfoxonium, (2-((3R,4S)-4-ethyl-1-((phenylmethoxy)carbonyl)-3-pyrrolidinyl)-2-oxoethyl)dimethyl-, inner salt, rel-
Pharmaceutical intermediate for synthesis
benzyl (3R,4S)-3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate
QEFUCTKHMXMWRF-KGLIPLIRSA-N
CC[C@@H]1CN(C[C@@H]1C(=O)CBr)C(=O)OCC2=CC=CC=C2